The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer
Authors:
Open Access
- 6 March 2014
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 44 (5) , 1512-1520
Abstract
SOX11 is involved in gastrulation and in malignant diseases. The aim of this study was to investigate the role of SOX11 in gastric cancer and its expression pattern and clinical significance. SOX11 overexpression cell model was used to examine in vitro and in vivo the role of SOX11 in cell growth and metastasis. Cell cycle analysis and Annexin V/PI double staining were used to investigate the effect of SOX11 on cell cycle progression and apoptosis. The expression of SOX11 in human gastric cancer was examined by immunohistochemistry. The correlation of SOX11 expression with clinicopathological characteristics and survival of patients was analyzed by Pearson's χ(2) and Kaplan-Meier analyses, respectively. Cox's proportional hazard model was employed in multivariate analysis. SOX11 overexpression did not inhibit cell growth but strongly suppressed cell migration/invasion in vitro and in vivo. We found a significant correlation between high SOX11 protein levels and Lauren's classification (intestinal type), differentiation status (high and medium), and early TNM stage. SOX11 is an independent prognostic factor for improved survival in gastric cancer patients. SOX11 was a potential tumor-suppressor and an independent positive prognostic factor in gastric cancer patients with less advanced clinicopathological features.Keywords
This publication has 21 references indexed in Scilit:
- The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylationBMC Cancer, 2011
- Gene Expression Signature–Based Prognostic Risk Score in Gastric CancerClinical Cancer Research, 2011
- SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignanciesMolecular Cancer, 2010
- Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric CancerPLOS Genetics, 2009
- The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancerEuropean Journal of Cancer, 2009
- The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survivalBritish Journal of Haematology, 2008
- The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular propertiesNucleic Acids Research, 2008
- ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cellsOncogene, 2006
- Gene Targeting Reveals a Widespread Role for the High-Mobility-Group Transcription Factor Sox11 in Tissue RemodelingMolecular and Cellular Biology, 2004
- Sox10 Is an Active Nucleocytoplasmic Shuttle Protein, and Shuttling Is Crucial for Sox10-Mediated TransactivationMolecular and Cellular Biology, 2002